Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-2206 in Recurrent and Metastatic Nasopharyngeal Carcinoma
NCT01370070Phase 2Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jul 2011
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MK-2206 in nasopharyngeal carcinoma (NPC), sponsored by The Chinese University of Hong Kong. Started Jul 2011; status: completed.
02
Drugs
MK-2206
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01370070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370070.